FAC Explorer

Finding 1078656 (2021-001)

Significant Deficiency Repeat Finding
Requirement
P
Questioned Costs
-
Year
2021
Accepted
2024-10-10
Audit: 324370
Organization: American Association of Physics Teachers, Inc. (MD)
Auditor: Gary Staples Accounting LLC

AI Summary

  • Core Issue: AAPT failed to file its annual financial report and single audit on time, risking non-profit status and future federal funding.
  • Impacted Requirements: Compliance with New York law and federal regulations regarding timely audit submissions.
  • Recommended Follow-Up: AAPT should enhance month-end and year-end closing procedures and enforce new policies to ensure timely financial reporting.

Finding Text

Finding 2021-001: State Audit Law and Single Audit Reporting Federal Program: Research and Development Cluster (Education and Human Resources) Assistance Listing Number and Title: 47.076 STEM Education Name of Federal Agency, Pass Through Entity (when applicable), Award Number and Year: National Science Foundation: 1431638 (9/1/2014 – 8/31/2022), 1524963 (11/1/2015 – 9/30/2021), 1500529 (9/1/2015 – 8/31/2022), 1624185 (9/16/2016 – 8/31/2022), 1640791 (9/15/2016 – 8/31/2022), 1720869 (5/15/2017 – 4/30/2022), 1726113 (8/1/2017 – 9/30/2023), 1821462 (7/1/2018 – 6/30/2024), 1812860 (9/1/2018 – 8/31/2020), 1940925 (1/15/2020 – 12/31/2023), 1907950 (7/1/2019 – 6/30/2024), 2015205 (4/1/2020 – 3/31/2022), 2021059 (10/1/2020 – 9/30/2024) Federal Program: Research and Development Cluster (Mathematical and Physical Sciences) Assistance Listing Number and Title: 47.049 Mathematical and Physical Sciences Name of Federal Agency, Pass Through Entity, Award Number and Year: National Science Foundation: 1821372 (10/1/2018 – 9/30/2024 pass through entity American Physical Society), 1834530 (9/1/2018 – 8/31/2025 pass through entity American Physical Society), 1938815 (8/1/2020 – 7/31/2024) Federal Program: Research and Development Cluster (Science) Assistance Listing Number and Title: 43.001 Science Name of Federal Agency, Pass Through Entity: National Aeronautics and Space Administration: NNX16AR36A (8/24/2016 – 8/23/2021 pass through entity Temple University of the Commonwealth System of Higher Education), 80NSSC21K1560 (6/28/2021 – 6/27/2022 pass through entity Temple University of the Commonwealth System of Higher Education) Significant Deficiency in Internal Controls Over Compliance, Other matters Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Per Executive Article 7-A, Section 172-B of New York law, non-profit organizations chartered in the State of New York were required to complete and file their annual financial report including the audit by May 15 of the following year for non-profits with a fiscal year end of December 31st. An automatic six month extension has been granted by the New York State Attorney General’s Charities Bureau to all non-profits since 2015. With this automatic extension, the due date to file the annual financial report including the audit was November 15, 2022. Title 2, Part 200 Section 512 of the Code of Federal Regulations states that an auditee’s audit required under Title 2, Part 200 Section 501 must be completed and the data collection form and reporting package submitted within the earlier of 30 days after the receipt of the auditor’s report(s) or nine months after the end of the audit period. The due date to file the audit was September 30, 2022. Condition: AAPT did not timely file the audit with the annual financial report with the State of New York. AAPT did not timely file the single audit with the Federal Clearing House. Cause: AAPT was unable to perform their year-end close timely and retain an auditor in order to have the annual audit completed. Effect or Potential Effect: New York law permits the State’s Attorney General to revoke non-profit status when audits are not filed timely. Federal awarding agencies may take actions including determining to not award grants to entities who are not compliant with regulations, and audit findings can restrict AAPT's ability to negotiate an indirect cost rate with the Federal government. Questioned Costs: None noted. Identification as a Repeat Finding, if Applicable: 2020-001 Recommendation: We recommend that AAPT implement procedures to enhance its month-end and year-end close procedures to improve the ability of AAPT to produce financial data to meet the criteria established by Executive Article 7-A, Section 172-B of New York law. Views of Responsible Officials and Planned Corrective Actions: AAPT has institute new policies and deadlines for staff to submit the required documentation in order for the accounting department to close the monthly books on a more timely and accurate financial statements. The polices include new staff repercussions for not following the new policies up to termination of employment. Anticipated Completion Date: 10/15/2024 Responsible Official: Michael Brosnan, CFO

Categories

Reporting Significant Deficiency

Other Findings in this Audit

  • 502204 2021-001
    Significant Deficiency Repeat
  • 502205 2021-002
    Material Weakness Repeat
  • 502206 2021-005
    Significant Deficiency Repeat
  • 502207 2021-001
    Significant Deficiency Repeat
  • 502208 2021-002
    Material Weakness Repeat
  • 502209 2021-003
    Material Weakness Repeat
  • 502210 2021-005
    Significant Deficiency Repeat
  • 502211 2021-001
    Significant Deficiency Repeat
  • 502212 2021-002
    Material Weakness Repeat
  • 502213 2021-005
    Significant Deficiency Repeat
  • 502214 2021-001
    Significant Deficiency Repeat
  • 502215 2021-002
    Material Weakness Repeat
  • 502216 2021-004
    Significant Deficiency Repeat
  • 502217 2021-005
    Significant Deficiency Repeat
  • 502218 2021-001
    Significant Deficiency Repeat
  • 502219 2021-002
    Material Weakness Repeat
  • 502220 2021-005
    Significant Deficiency Repeat
  • 502221 2021-006
    Significant Deficiency Repeat
  • 502222 2021-001
    Significant Deficiency Repeat
  • 502223 2021-002
    Material Weakness Repeat
  • 502224 2021-005
    Significant Deficiency Repeat
  • 502225 2021-001
    Significant Deficiency Repeat
  • 502226 2021-002
    Material Weakness Repeat
  • 502227 2021-004
    Significant Deficiency Repeat
  • 502228 2021-005
    Significant Deficiency Repeat
  • 502229 2021-001
    Significant Deficiency Repeat
  • 502230 2021-002
    Material Weakness Repeat
  • 502231 2021-005
    Significant Deficiency Repeat
  • 502232 2021-001
    Significant Deficiency Repeat
  • 502233 2021-002
    Material Weakness Repeat
  • 502234 2021-003
    Material Weakness Repeat
  • 502235 2021-005
    Significant Deficiency Repeat
  • 502236 2021-001
    Significant Deficiency Repeat
  • 502237 2021-002
    Material Weakness Repeat
  • 502238 2021-005
    Significant Deficiency Repeat
  • 502239 2021-001
    Significant Deficiency Repeat
  • 502240 2021-002
    Material Weakness Repeat
  • 502241 2021-005
    Significant Deficiency Repeat
  • 502242 2021-001
    Significant Deficiency Repeat
  • 502243 2021-002
    Material Weakness Repeat
  • 502244 2021-005
    Significant Deficiency Repeat
  • 502245 2021-001
    Significant Deficiency Repeat
  • 502246 2021-002
    Material Weakness Repeat
  • 502247 2021-005
    Significant Deficiency Repeat
  • 502248 2021-001
    Significant Deficiency Repeat
  • 502249 2021-002
    Material Weakness Repeat
  • 502250 2021-005
    Significant Deficiency Repeat
  • 502251 2021-001
    Significant Deficiency Repeat
  • 502252 2021-002
    Material Weakness Repeat
  • 502253 2021-005
    Significant Deficiency Repeat
  • 502254 2021-001
    Significant Deficiency Repeat
  • 502255 2021-002
    Material Weakness Repeat
  • 502256 2021-005
    Significant Deficiency Repeat
  • 502257 2021-001
    Significant Deficiency Repeat
  • 502258 2021-002
    Material Weakness Repeat
  • 502259 2021-005
    Significant Deficiency Repeat
  • 1078646 2021-001
    Significant Deficiency Repeat
  • 1078647 2021-002
    Material Weakness Repeat
  • 1078648 2021-005
    Significant Deficiency Repeat
  • 1078649 2021-001
    Significant Deficiency Repeat
  • 1078650 2021-002
    Material Weakness Repeat
  • 1078651 2021-003
    Material Weakness Repeat
  • 1078652 2021-005
    Significant Deficiency Repeat
  • 1078653 2021-001
    Significant Deficiency Repeat
  • 1078654 2021-002
    Material Weakness Repeat
  • 1078655 2021-005
    Significant Deficiency Repeat
  • 1078657 2021-002
    Material Weakness Repeat
  • 1078658 2021-004
    Significant Deficiency Repeat
  • 1078659 2021-005
    Significant Deficiency Repeat
  • 1078660 2021-001
    Significant Deficiency Repeat
  • 1078661 2021-002
    Material Weakness Repeat
  • 1078662 2021-005
    Significant Deficiency Repeat
  • 1078663 2021-006
    Significant Deficiency Repeat
  • 1078664 2021-001
    Significant Deficiency Repeat
  • 1078665 2021-002
    Material Weakness Repeat
  • 1078666 2021-005
    Significant Deficiency Repeat
  • 1078667 2021-001
    Significant Deficiency Repeat
  • 1078668 2021-002
    Material Weakness Repeat
  • 1078669 2021-004
    Significant Deficiency Repeat
  • 1078670 2021-005
    Significant Deficiency Repeat
  • 1078671 2021-001
    Significant Deficiency Repeat
  • 1078672 2021-002
    Material Weakness Repeat
  • 1078673 2021-005
    Significant Deficiency Repeat
  • 1078674 2021-001
    Significant Deficiency Repeat
  • 1078675 2021-002
    Material Weakness Repeat
  • 1078676 2021-003
    Material Weakness Repeat
  • 1078677 2021-005
    Significant Deficiency Repeat
  • 1078678 2021-001
    Significant Deficiency Repeat
  • 1078679 2021-002
    Material Weakness Repeat
  • 1078680 2021-005
    Significant Deficiency Repeat
  • 1078681 2021-001
    Significant Deficiency Repeat
  • 1078682 2021-002
    Material Weakness Repeat
  • 1078683 2021-005
    Significant Deficiency Repeat
  • 1078684 2021-001
    Significant Deficiency Repeat
  • 1078685 2021-002
    Material Weakness Repeat
  • 1078686 2021-005
    Significant Deficiency Repeat
  • 1078687 2021-001
    Significant Deficiency Repeat
  • 1078688 2021-002
    Material Weakness Repeat
  • 1078689 2021-005
    Significant Deficiency Repeat
  • 1078690 2021-001
    Significant Deficiency Repeat
  • 1078691 2021-002
    Material Weakness Repeat
  • 1078692 2021-005
    Significant Deficiency Repeat
  • 1078693 2021-001
    Significant Deficiency Repeat
  • 1078694 2021-002
    Material Weakness Repeat
  • 1078695 2021-005
    Significant Deficiency Repeat
  • 1078696 2021-001
    Significant Deficiency Repeat
  • 1078697 2021-002
    Material Weakness Repeat
  • 1078698 2021-005
    Significant Deficiency Repeat
  • 1078699 2021-001
    Significant Deficiency Repeat
  • 1078700 2021-002
    Material Weakness Repeat
  • 1078701 2021-005
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
43.001 Science $41,592
47.049 Mathematical and Physical Sciences $23,501
47.076 Education and Human Resources $20,896